孕29周之前出生婴儿的孕妇糖尿病和神经发育结果
Adetokunbo Akinseye1, Christy Pylypjuk2, Diane Moddemann3
1Section of Neonatology, Department of Pediatrics and Child Health, Max Rady College of Medicine, University of Manitoba, Winnipeg, Canada.
The Journal of pediatrics
|September 21, 2024
概括
过早出生 (怀孕29周以下) 且暴露于母亲糖尿病的婴儿出现神经发育障碍 (NDI) 的比率更高. 这包括语言和运动迟缓,突出显示了宫内糖尿病暴露对婴儿发育的影响.
科学领域:
- 新生儿研究新生儿研究
- 发育儿科 发育儿科
- 孕产妇和胎儿的医学
背景情况:
- 患有糖尿病的孕妇对新生儿的结果越来越担心.
- 早产婴儿 (妊娠29周以下) 特别容易受到神经发育方面的挑战.
研究的目的:
- 为了比较神经发育结果,在怀孕29周以下出生的婴儿中,有或没有母体糖尿病暴露.
- 为了确定与子宫内糖尿病暴露相关的特定神经发育障碍.
主要方法:
- 使用加拿大新生儿网络和随访网络数据库 (2009-2018) 进行回顾性队列研究.
- 包括出生时<29周的婴儿,怀孕期评估在18-24个月的校正年龄.
- 主要结果:神经发育障碍 (NDI) 和显著的NDI (sNDI) 使用标准化评估;次要结果包括单个组件.
主要成果:
- 在13988名符合条件的婴儿中,55%完成了后续评估.
- 暴露于母亲糖尿病的婴儿有NDI的几率增加 (aOR1.09;95% CI1.08-1.54).
- 在暴露于糖尿病的组中,语言和运动延迟更频繁;在sNDI中没有观察到显著差异.
结论:
- 暴露于母体糖尿病的早产婴儿 (妊娠29周以下) 呈现较高的NDI率,包括语言和运动延迟.
- 需要进一步的研究来阐明这些发现的病因学和临床影响.
相关概念视频
Pathophysiology of Diabetes
900
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
900
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Diabetes: Symptoms, Diagnosis, and Complications
516
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
516


